Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Outset Medical Q4 2023 Adj EPS $(0.59) Beats $(0.61) Estimate, Sales $30.51M Beat $30.40M Estimate

Author: Benzinga Newsdesk | February 21, 2024 05:24pm
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.61) by 3.28 percent. The company reported quarterly sales of $30.51 million which beat the analyst consensus estimate of $30.40 million by 0.34 percent. This is a 4.69 percent decrease over sales of $32.01 million the same period last year.

Posted In: OM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist